<p>N-Acetylcysteine to Combat COVID-19: An Evidence Review</p>
Zhongcheng Shi, Carlos A Puyo
Therapeutics and Clinical Risk Management, doi:10.2147/tcrm.s273700
The novel coronavirus disease (COVID-19) is caused by a virus (SARS-Cov-2) and is known for inducing multisystem organ dysfunction associated with significant morbidity and mortality. Current therapeutic strategies for COVID-19 have failed to effectively reduce mortality rate, especially for elderly patients. A newly developed vaccine against SARS-Cov-2 has been reported to induce the production of neutralizing antibodies in young volunteers. However, the vaccine has shown limited benefit in the elderly, suggesting an agedependent immune response. As a result, exploring new applications of existing medications could potentially provide valuable treatments for COVID-19. N-acetylcysteine (NAC) has been used in clinical practice to treat critically ill septic patients, and more recently for COVID-19 patients. NAC has antioxidant, anti-inflammatory and immune-modulating characteristics that may prove beneficial in the treatment and prevention of SARS-Cov-2. This review offers a thorough analysis of NAC and discusses its potential use for treatment of COVID-19.
Conclusions N-acetylcysteine (NAC) is inexpensive, has very low toxicity, has been FDA approved for many years, and has the potential to improve therapeutic strategies for COVID-19. NAC administered intravenously, orally, or inhaled, may suppress SARS-CoV-2 replication and may improve outcomes if used timely. Potential therapeutic benefits of NAC include, extracellularly scavenging ROS radicals, replenishing intracellular GSH, suppression of cytokine storm, and T cell protection, thus mitigating inflammation and tissue injury. NAC administration in combination with other antiviral agents may dramatically reduce hospital admission rate, mechanical ventilation and mortality.
Disclosure The authors report no conflicts of interest for this work.
Therapeutics and Clinical Risk Management
Dovepress
References
Allegra, Sasso, Bovio, Human Neutrophil Oxidative Bursts and their in vitro Modulation by Different N-Acetylcysteine Concentrations, Drug Res
Aruoma, Halliwell, Hoey, The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid, Free Radic Biol Med,
doi:10.1016/0891-5849(89)90066-XBao, Ye, Gong, Humanized monoclonal antibody against the chemokine CXCL-8 (IL-8) effectively prevents acute lung injury, Int Immunopharmacol,
doi:10.1016/j.intimp.2009.11.005Chiba, Takahashi, Sato, Fas-mediated apoptosis is modulated by intracellular glutathione in human T cells, Eur J Immunol,
doi:10.1002/eji.1830260530Cruz, Helms, Aquino, DNA-bound elastase of neutrophil extracellular traps degrades plasminogen, reduces plasmin formation, and decreases fibrinolysis: proof of concept in septic shock plasma, FASEB J,
doi:10.1096/fj.201901363RRRDósa, Helta, Radovits, Dose escalation study of intravenous and intra-arterial N-acetylcysteine for the prevention of oto-and nephrotoxicity of cisplatin with a contrast-induced nephropathy model in patients with renal insufficiency, Fluids and Barriers of the CNS,
doi:10.1186/s12987-017-0075-0Flora, Grassi, Carati, Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment, Eur Respiratory J,
doi:10.1183/09031936.97.10071535Fox, Prevention of granulocyte-mediated oxidant lung injury in rats by a hydroxyl radical scavenger, dimethylthiourea, J Clin Invest,
doi:10.1172/JCI111558Geiler, Michaelis, Naczk, N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus, Biochem Pharmacol,
doi:10.1016/j.bcp.2009.08.025Green, Heard, Reynolds, Oral and Intravenous Acetylcysteine for Treatment of Acetaminophen Toxicity: A Systematic Review and Meta-analysis, West J Emerg Med,
doi:10.5811/westjem.2012.4.6885Guthappa, Molecular Docking Studies of N-Acetyl Cysteine, Zinc Acetyl Cysteine and Niclosamide on SARS Cov 2 Protease and Its Comparison with Hydroxychloroquine, Chemarxiv,
doi:10.26434/chemrxiv.12161493.v1Hassett, Curley, Contreras, Overexpression of pulmonary extracellular superoxide dismutase attenuates endotoxin induced acute lung injury, Intensive Care Med
Ho, Douglas, Glutathione and N-Acetylcysteine suppression of human immunodeficiency virus replication in human Monocyte/ Macrophages in vitro, AIDS Res Hum Retroviruses,
doi:10.1089/aid.1992.8.1249Hong, Gil, Yang, Effect of High-Dose Intravenous N-acetylcysteine on the Concentration of Plasma Sulfur-Containing Amino Acids, Korean J Intern Med,
doi:10.3904/kjim.2005.20.3.217Huang, Su, Theron, An interferon-γ-related cytokine storm in SARS patients, J Med Virol,
doi:10.1002/jmv.20255Ibrahim, Smith, Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous n-acetylcysteine, Clin Immunol,
doi:10.1016/j.clim.2020.108544Jamwal, Gautam, Elsworth, An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic, Life Sci,
doi:10.1016/j.lfs.2020.118105Kharazmi, Nielsen, Schiotx, N-acetylcysteine inhibits human neutrophil and monocyte chemotaxis and oxidative metabolism, Int J Lmmunopharmac,
doi:10.1016/0192-0561(88)90148-8Lai, Hanczko, Bonilla, N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial, Arthritis Rheumatology,
doi:10.1002/art.34502Leonard-Lorant, Delabranche, Severac, Acute Pulmonary Embolism in Patients with COVID-19 at CT Angiography and Relationship to d-Dimer Levels, Radiology,
doi:10.1148/radiol.2020201561Li, Huang, Wang, Acute lung injury in patients with COVID-19 infection, Clin Transl Med,
doi:10.1002/ctm2.16Li, Wang, Zhong, Age-dependent risks of Incidence and Mortality of COVID-19 in Hubei Province and Other Parts of China, Fron Med,
doi:10.3389/fmed.2020.00190Liu, Luo, Qian, Experience of N-acetylcysteine airway management in the successful treatment of one case of critical condition with COVID-19, Researchsquare,
doi:10.21203/rs.3.rs-34193/v1Ma, Shi, Fan, Predictive Value of the Neutrophil-to-Lymphocyte Ratio (NLR) for diagnosis and worse clinical course of the COVID-19: findings from ten provinces in China, Lancet,
doi:10.2139/ssrn.3569838Macdonald, The gut is still the biggest lymphoid organ in the body, Nature
Mata, Sarrion, Armengot, Respiratory syncytial virus inhibits ciliagenesis in differentiated normal human bronchial epithelial cells: effectiveness of N-Acetylcysteine, PLoS One,
doi:10.1371/journal.pone.0048037Molnar, Shearer, Lowe, N-Acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective, randomized, placebo-controlled study, DovePress Therapeutics and Clinical Risk Management,
doi:10.1097/00003246-199906000-00028Moradi, Mojtahedzadeh, Mandegari, The role of glutathione-S-transferase polymorphisms on clinical outcome of ALI/ARDS patient treated with N-acetylcysteine, Respir Med,
doi:10.1016/j.rmed.2008.09.013Mukaida, Matsumoto, Yokoi, Inhibition of neutrophil-mediated acute inflammatory injury by an antibody against interleukin-8 (IL-8), Inflammation Res,
doi:10.1007/s000110050308Nasia, Mcardleb, Gaudernackc, Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention, Toxicol Rep,
doi:10.1016/j.toxrep.2020.06.003Poppe, Wittig, Jurida, The NF-κB-dependent andindependent transcriptome and chromatin landscapes of human coronavirus 229E-infected cells, PLoS Pathog,
doi:10.1371/journal.ppat.1006286Puyo, Kreig, Saddi, Case Report: use of hydroxychloroquine and N-acetylcysteine for treatment of a COVID-19 positive patient [version 1; peer review: awaiting peer review, F1000Research
Qin, Zhou, Hu, Dysregulation of immune response in patients with COVID-19 in Wuhan, China, Clin Infect Dis,
doi:10.1093/cid/ciaa248Sadowskaa, Manuel-Y-Keenoy, Vertongen, Effect of N-acetylcysteine on neutrophil activation markers in healthy volunteers: in vivo and in vitro study, Pharmacol Res,
doi:10.1016/j.phrs.2005.11.003Saule, Trauet, Dutriez, Accumulation of memory T cells from childhood to old age, Central and effector memory cells in CD4 + versus effector memory and terminally differentiated memory cells in CD8+ compartment, Mech Ageing Dev,
doi:10.1016/j.mad.2005.11.001Sharafkhah, Abdolrazaghnejad, Zarinfar, Safety and efficacy of N-acetylcysteine for prophylaxis of ventilator-associated pneumonia: a randomized, double blind, placebo-controlled clinical trial, Mojtaba Med Gas Res,
doi:10.4103/2045-9912.229599Stegelmeier, Van Vloten, Mould, Myeloid Cells during Viral Infections and Inflammation, Viruses,
doi:10.3390/v11020168Suter, Domenighetti, Schaller, N-Acetylcysteine enhances recovery from acute lung injury in man: a randomized, double-blind, placebo-controlled clinical study, Chest,
doi:10.1378/chest.105.1.190Tavakolpour, Rakhshandehroo, Wei, Rashidian, Lymphopenia during the COVID-19 infection: what it shows and what can be learned, Immunol Lett,
doi:10.1016/j.imlet.2020.06.013Thierry, Anti-protease Treatments Targeting Plasmin(ogen) and Neutrophil Elastase May Be Beneficial in Fighting COVID-19, Physiol Rev,
doi:10.1152/physrev.00019.2020Wayne, Rhyne, Garry, Cell-Mediated Immunity as a Predictor of Morbidity and Mortality in Subjects Over 60, J Gerontol,
doi:10.1093/geronj/45.2.M45Yazdi, Razavi, Sheikh, Clinical Trial Assessment of Intermittent and Continuous Infusion Dose of N-Acetylcysteine on Redox Status of the Body in Patients with Sepsis Admitted to the ICU, J Intensive Care Med,
doi:10.1177/0885066618823152Zhang, Ju, Ma, N-acetylcysteine improves oxidative stress and inflammatory response in patients with community acquired pneumonia A randomized controlled trial, Medicine
Zhang, Lin, Sun, Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science
Zhang, Zhou, Zhu, Immune phenotyping based on neutrophil-to-lymphocyte ratio and IgG predicts disease severity and outcome for patients with COVID-19, medRxiv,
doi:10.1101/2020.03.12.20035048Zhu, Li, Guan, Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial, Lancet,
doi:10.1016/S0140-6736(20)31208-3DOI record:
{
"DOI": "10.2147/tcrm.s273700",
"ISSN": [
"1178-203X"
],
"URL": "http://dx.doi.org/10.2147/TCRM.S273700",
"author": [
{
"ORCID": "http://orcid.org/0000-0001-9267-4536",
"affiliation": [],
"authenticated-orcid": true,
"family": "Shi",
"given": "Zhongcheng",
"sequence": "first"
},
{
"ORCID": "http://orcid.org/0000-0002-2481-0513",
"affiliation": [],
"authenticated-orcid": true,
"family": "Puyo",
"given": "Carlos A",
"sequence": "additional"
}
],
"container-title": "Therapeutics and Clinical Risk Management",
"container-title-short": "TCRM",
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2020,
11,
1
]
],
"date-time": "2020-11-01T20:04:15Z",
"timestamp": 1604261055000
},
"deposited": {
"date-parts": [
[
2020,
11,
1
]
],
"date-time": "2020-11-01T20:04:20Z",
"timestamp": 1604261060000
},
"indexed": {
"date-parts": [
[
2024,
9,
14
]
],
"date-time": "2024-09-14T03:09:42Z",
"timestamp": 1726283382729
},
"is-referenced-by-count": 89,
"issued": {
"date-parts": [
[
2020,
11
]
]
},
"language": "en",
"license": [
{
"URL": "http://creativecommons.org/licenses/by-nc/3.0/",
"content-version": "unspecified",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2020,
11,
1
]
],
"date-time": "2020-11-01T00:00:00Z",
"timestamp": 1604188800000
}
}
],
"link": [
{
"URL": "https://www.dovepress.com/getfile.php?fileID=63267",
"content-type": "application/pdf",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://www.dovepress.com/getfile.php?fileID=63267",
"content-type": "application/pdf",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "301",
"original-title": [],
"page": "1047-1055",
"prefix": "10.2147",
"published": {
"date-parts": [
[
2020,
11
]
]
},
"published-online": {
"date-parts": [
[
2020,
11
]
]
},
"publisher": "Informa UK Limited",
"reference": [
{
"DOI": "10.1016/j.lfs.2020.118105",
"author": "Jamwal",
"doi-asserted-by": "publisher",
"first-page": "118105",
"journal-title": "Life Sci",
"key": "ref1",
"volume": "257",
"year": "2020"
},
{
"DOI": "10.1016/S0140-6736(20)30183-5",
"author": "Huang",
"doi-asserted-by": "publisher",
"first-page": "497",
"journal-title": "Lancet",
"key": "ref2",
"volume": "395",
"year": "2020"
},
{
"DOI": "10.1002/jmv.20255",
"author": "Huang",
"doi-asserted-by": "publisher",
"first-page": "185",
"journal-title": "J Med Virol",
"key": "ref3",
"volume": "75",
"year": "2005"
},
{
"DOI": "10.3390/v11020168",
"author": "Stegelmeier",
"doi-asserted-by": "publisher",
"first-page": "168",
"journal-title": "Viruses",
"key": "ref4",
"volume": "11",
"year": "2019"
},
{
"DOI": "10.1016/j.cell.2020.08.001",
"author": "Schulte-Schrepping",
"doi-asserted-by": "publisher",
"first-page": "1419",
"journal-title": "Cell",
"key": "ref5",
"volume": "182",
"year": "2020"
},
{
"DOI": "10.1146/annurev.me.36.020185.001231",
"author": "Janoff",
"doi-asserted-by": "publisher",
"first-page": "207",
"journal-title": "Ann Rev Med",
"key": "ref6",
"volume": "36",
"year": "1985"
},
{
"DOI": "10.1152/physrev.00019.2020",
"author": "Thierry",
"doi-asserted-by": "publisher",
"first-page": "1597",
"journal-title": "Physiol Rev",
"key": "ref7",
"volume": "100",
"year": "2020"
},
{
"DOI": "10.1096/fj.201901363RRR",
"author": "Cruz",
"doi-asserted-by": "publisher",
"journal-title": "FASEB J",
"key": "ref8",
"year": "2020"
},
{
"DOI": "10.1148/radiol.2020201561",
"author": "Leonard-Lorant",
"doi-asserted-by": "publisher",
"first-page": "E189",
"journal-title": "Radiology",
"key": "ref9",
"volume": "296",
"year": "2020"
},
{
"DOI": "10.21203/rs.3.rs-18340/v1",
"author": "Xu",
"doi-asserted-by": "publisher",
"journal-title": "Res Square",
"key": "ref10",
"year": "2020"
},
{
"DOI": "10.1007/s000110050308",
"author": "Mukaida",
"doi-asserted-by": "publisher",
"first-page": "151",
"journal-title": "Inflammation Res",
"key": "ref11",
"volume": "47",
"year": "1998"
},
{
"DOI": "10.1016/j.intimp.2009.11.005",
"author": "Bao",
"doi-asserted-by": "publisher",
"first-page": "259",
"journal-title": "Int Immunopharmacol",
"key": "ref12",
"volume": "10",
"year": "2010"
},
{
"DOI": "10.1093/geronj/45.2.M45",
"author": "Wayne",
"doi-asserted-by": "publisher",
"first-page": "45",
"journal-title": "J Gerontol",
"key": "ref13",
"volume": "45",
"year": "1990"
},
{
"DOI": "10.1111/j.1447-0594.2004.00162.x",
"author": "Ohrui",
"doi-asserted-by": "publisher",
"first-page": "92",
"journal-title": "Geriatr Gerontol Int",
"key": "ref14",
"volume": "4",
"year": "2004"
},
{
"DOI": "10.1016/j.mad.2005.11.001",
"author": "Saule",
"doi-asserted-by": "publisher",
"first-page": "274",
"journal-title": "Mech Ageing Dev",
"key": "ref15",
"volume": "127",
"year": "2006"
},
{
"DOI": "10.3389/fmed.2020.00190",
"author": "Li",
"doi-asserted-by": "publisher",
"first-page": "214",
"journal-title": "Fron Med",
"key": "ref16",
"year": "2015"
},
{
"DOI": "10.1101/2020.03.12.20035048",
"author": "Zhang",
"doi-asserted-by": "publisher",
"journal-title": "medRxiv",
"key": "ref17",
"year": "2020"
},
{
"DOI": "10.2139/ssrn.3569838",
"author": "Ma",
"doi-asserted-by": "publisher",
"journal-title": "Lancet",
"key": "ref18",
"year": "2020"
},
{
"DOI": "10.1093/cid/ciaa248",
"author": "Qin",
"doi-asserted-by": "publisher",
"first-page": "148",
"journal-title": "Clin Infect Dis",
"key": "ref19",
"volume": "14",
"year": "2015"
},
{
"DOI": "10.1016/S0140-6736(20)31208-3",
"author": "Zhu",
"doi-asserted-by": "publisher",
"journal-title": "Lancet",
"key": "ref20",
"year": "2020"
},
{
"DOI": "10.1183/09031936.97.10071535",
"author": "Flora",
"doi-asserted-by": "publisher",
"first-page": "1535",
"journal-title": "Eur Respiratory J",
"key": "ref21",
"volume": "10",
"year": "1997"
},
{
"DOI": "10.1371/journal.ppat.1006286",
"author": "Poppe",
"doi-asserted-by": "publisher",
"first-page": "e1006286",
"journal-title": "PLoS Pathog",
"key": "ref22",
"volume": "13",
"year": "2017"
},
{
"DOI": "10.1016/j.bcp.2009.08.025",
"author": "Geiler",
"doi-asserted-by": "publisher",
"first-page": "413",
"journal-title": "Biochem Pharmacol",
"key": "ref23",
"volume": "79",
"year": "2010"
},
{
"DOI": "10.1089/aid.1992.8.1249",
"author": "Ho",
"doi-asserted-by": "publisher",
"first-page": "1249",
"journal-title": "AIDS Res Hum Retroviruses",
"key": "ref24",
"volume": "8",
"year": "1992"
},
{
"DOI": "10.1371/journal.pone.0048037",
"author": "Mata",
"doi-asserted-by": "publisher",
"first-page": "e48037",
"journal-title": "PLoS One",
"key": "ref25",
"volume": "7",
"year": "2012"
},
{
"DOI": "10.1126/science.abb3405",
"author": "Zhang",
"doi-asserted-by": "crossref",
"first-page": "409",
"journal-title": "Science",
"key": "ref26",
"volume": "368",
"year": "2020"
},
{
"DOI": "10.26434/chemrxiv.12161493.v1",
"author": "Guthappa",
"doi-asserted-by": "publisher",
"journal-title": "Chemarxiv",
"key": "ref27",
"year": "2020"
},
{
"DOI": "10.1016/j.phrs.2005.11.003",
"author": "Sadowskaa",
"doi-asserted-by": "publisher",
"first-page": "216",
"journal-title": "Pharmacol Res",
"key": "ref28",
"volume": "53",
"year": "2006"
},
{
"DOI": "10.1016/0192-0561(88)90148-8",
"author": "Kharazmi",
"doi-asserted-by": "publisher",
"first-page": "39",
"journal-title": "Int J Lmmunopharmac",
"key": "ref29",
"volume": "10",
"year": "1988"
},
{
"author": "Allegra",
"first-page": "669",
"journal-title": "Drug Res",
"key": "ref30",
"volume": "52",
"year": "2002"
},
{
"DOI": "10.1016/j.imlet.2020.06.013",
"author": "Tavakolpour",
"doi-asserted-by": "publisher",
"first-page": "31",
"journal-title": "Immunol Lett",
"key": "ref31",
"volume": "225",
"year": "2020"
},
{
"DOI": "10.1002/eji.1830260530",
"author": "Chiba",
"doi-asserted-by": "publisher",
"first-page": "1164",
"journal-title": "Eur J Immunol",
"key": "ref32",
"volume": "26",
"year": "1996"
},
{
"DOI": "10.1002/art.34502",
"author": "Lai",
"doi-asserted-by": "publisher",
"first-page": "2937",
"journal-title": "Arthritis Rheumatology",
"key": "ref33",
"volume": "64",
"year": "2012"
},
{
"DOI": "10.4103/2045-9912.229599",
"author": "Sharafkhah",
"doi-asserted-by": "publisher",
"first-page": "19",
"journal-title": "Mojtaba Med Gas Res",
"key": "ref34",
"volume": "8",
"year": "2018"
},
{
"DOI": "10.1097/MD.0000000000013087",
"author": "Zhang",
"doi-asserted-by": "crossref",
"first-page": "e13087",
"journal-title": "Medicine",
"key": "ref35",
"volume": "97",
"year": "2018"
},
{
"DOI": "10.3389/fimmu.2020.01446",
"author": "Ragab",
"doi-asserted-by": "publisher",
"journal-title": "Front Immunol",
"key": "ref36",
"volume": "11",
"year": "2020"
},
{
"DOI": "10.1007/s00134-011-2309-y",
"author": "Hassett",
"doi-asserted-by": "crossref",
"first-page": "1680",
"journal-title": "Intensive Care Med",
"key": "ref37",
"volume": "37",
"year": "2011"
},
{
"DOI": "10.1172/JCI111558",
"author": "Fox",
"doi-asserted-by": "publisher",
"first-page": "1456",
"journal-title": "J Clin Invest",
"key": "ref38",
"volume": "74",
"year": "1984"
},
{
"DOI": "10.1002/ctm2.16",
"author": "Li",
"doi-asserted-by": "publisher",
"journal-title": "Clin Transl Med",
"key": "ref39",
"year": "2020"
},
{
"DOI": "10.1016/0891-5849(89)90066-X",
"author": "Aruoma",
"doi-asserted-by": "publisher",
"first-page": "593",
"journal-title": "Free Radic Biol Med",
"key": "ref40",
"volume": "6",
"year": "1989"
},
{
"DOI": "10.1378/chest.105.1.190",
"author": "Suter",
"doi-asserted-by": "publisher",
"first-page": "190",
"journal-title": "Chest",
"key": "ref41",
"volume": "105",
"year": "1994"
},
{
"DOI": "10.7326/0003-4819-152-10-201005180-00017",
"author": "Lai",
"doi-asserted-by": "publisher",
"first-page": "687",
"journal-title": "Ann Intern Med",
"key": "ref42",
"volume": "152",
"year": "2010"
},
{
"DOI": "10.1016/j.rmed.2008.09.013",
"author": "Moradi",
"doi-asserted-by": "publisher",
"first-page": "434",
"journal-title": "Respir Med",
"key": "ref43",
"volume": "103",
"year": "2009"
},
{
"author": "Puyo",
"first-page": "491",
"journal-title": "F1000Research",
"key": "ref44",
"volume": "9",
"year": "2020"
},
{
"DOI": "10.21203/rs.3.rs-34193/v1",
"author": "Liu",
"doi-asserted-by": "publisher",
"journal-title": "Researchsquare",
"key": "ref45",
"year": "2020"
},
{
"DOI": "10.1016/j.toxrep.2020.06.003",
"author": "Nasia",
"doi-asserted-by": "publisher",
"first-page": "768",
"journal-title": "Toxicol Rep",
"key": "ref46",
"volume": "7",
"year": "2020"
},
{
"DOI": "10.1016/j.clim.2020.108544",
"author": "Ibrahim",
"doi-asserted-by": "publisher",
"first-page": "108544",
"journal-title": "Clin Immunol",
"key": "ref47",
"volume": "219",
"year": "2020"
},
{
"key": "ref48",
"unstructured": "ACETADOTE® (acetylcysteine) Injection. NDA 21-539/S-004. FDA. 2006"
},
{
"DOI": "10.1186/s12987-017-0075-0",
"author": "Dósa",
"doi-asserted-by": "publisher",
"first-page": "26",
"journal-title": "Fluids and Barriers of the CNS",
"key": "ref49",
"volume": "14",
"year": "2017"
},
{
"DOI": "10.3904/kjim.2005.20.3.217",
"author": "Hong",
"doi-asserted-by": "publisher",
"first-page": "217",
"journal-title": "Korean J Intern Med",
"key": "ref50",
"volume": "20",
"year": "2005"
},
{
"author": "MacDonald",
"first-page": "246",
"journal-title": "Nature",
"key": "ref51",
"volume": "1",
"year": "2008"
},
{
"DOI": "10.5811/westjem.2012.4.6885",
"author": "Green",
"doi-asserted-by": "publisher",
"first-page": "218",
"journal-title": "West J Emerg Med",
"key": "ref52",
"volume": "14",
"year": "2013"
},
{
"DOI": "10.1056/NEJMoa2007016",
"author": "Grein",
"doi-asserted-by": "publisher",
"first-page": "2327",
"journal-title": "NEJM",
"key": "ref53",
"volume": "382",
"year": "2020"
},
{
"DOI": "10.1177/0885066618823152",
"author": "Yazdi",
"doi-asserted-by": "publisher",
"journal-title": "J Intensive Care Med",
"key": "ref54",
"year": "2019"
},
{
"DOI": "10.1097/00003246-199906000-00028",
"author": "Molnar",
"doi-asserted-by": "publisher",
"first-page": "1100",
"journal-title": "Crit Care Med",
"key": "ref55",
"volume": "27",
"year": "1999"
}
],
"reference-count": 55,
"references-count": 55,
"relation": {},
"resource": {
"primary": {
"URL": "https://www.dovepress.com/n-acetylcysteine-to-combat-covid-19-an-evidence-review-peer-reviewed-article-TCRM"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"title": "<p>N-Acetylcysteine to Combat COVID-19: An Evidence Review</p>",
"type": "journal-article",
"volume": "Volume 16"
}
